348090 <common-name>N-(4-bromo-2-methylphenyl)-2-[[5-(4-tert-butylphenyl)-4-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide</common-name> <description>N-(4-bromo-2-methylphenyl)-2-[[5-(4-tert-butylphenyl)-4-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide is a chemical compound with the formula C28H29BrN4O2S. With an average molecular weight of 565.50 g/mol, N-(4-bromo-2-methylphenyl)-2-[[5-(4-tert-butylphenyl)-4-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide is a heavy molecule.</description> <cas>477313-57-8</cas> <pubchem-id>1623328</pubchem-id> <chemical-formula>C28H29BrN4O2S</chemical-formula> <weight>565.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T11:58:35Z</created-at> <updated-at type="dateTime">2026-08-31T11:58:35Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=C(C=CC(=C1)Br)NC(=O)CSC2=NN=C(N2C3=CC=C(C=C3)OC)C4=CC=C(C=C4)C(C)(C)C</moldb-smiles> <moldb-formula>C28H29BrN4O2S</moldb-formula> <moldb-inchi>InChI=1S/C28H29BrN4O2S/c1-18-16-21(29)10-15-24(18)30-25(34)17-36-27-32-31-26(19-6-8-20(9-7-19)28(2,3)4)33(27)22-11-13-23(35-5)14-12-22/h6-16H,17H2,1-5H3,(H,30,34)</moldb-inchi> <moldb-inchikey>YZYNUERUMQZMEX-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">564.11946</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.2</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM343983</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-(4-bromo-2-methylphenyl)-2-[[5-(4-tert-butylphenyl)-4-(4-methoxyphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0298425</sync-id> <structure-inchikey>YZYNUERUMQZMEX-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>404000200000800000002800000000000000000000000000004000000000000000080000200004008000002080800000000000000000000000200000000000000000000000000000000000000020000000000100000200800010000200040000010000010040000000100000800400000100000000000000000000000000000040000000000000000000000084880000010000000080000000000000000040000000001000000000080100000040000020410000000000002c00000080000800000000000000000100000000400000000000002000000200000000000000008040000000800040000000000400000008010000000040000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMGQCgAAAAD BAZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEj ACAAAAABBwBoAAAAAwIBBgAoAAAAAwQIACgAAAADAgYAYAAAAAICEAAgAAAA AgZAKAAAAAMEB0AoAAAAAwMHQCgAAAADAwZAKAAAAAMEB0AoAAAAAwMGQCgA AAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAA AwMBCAAoAAAAAwIGAGAAAAABAwZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMB BkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGACAAAAAEBgBgAAAAAQMGAGAA AAABAwYAYAAAAAEDCwABAAECaAwCA2gMAwRoDAQFaAwFBmgMBQcAAgggCAkg CQooAgkLAAsMAAwNAA0OaAwOD2gMDxBoDBARaAwREiASE2gMExRoDBQVaAwV FmgMFhdoDBUYIBgZABAaIBobaAwbHGgMHB1oDB0eaAweH2gMHSAAICEAICIA ICMABgFoDBENaAwXEmgMHxpoDEIEAAAABgEGBQQDAgUODREQDwYTFBUWFxIG GxwdHh8aFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:34Z</structure-indexed-at> </compound>